Acenocoumarol | List of Frontiers open access articles

Original Research

Published on 29 Mar 2022

Development of a Fluorescent Microfluidic Device Based on Antibody Microarray Read-Out for Therapeutic Drug Monitoring of Acenocoumarol

in Biosensors and Biomolecular Electronics

J.-Pablo Salvador
Thomas Brettschneider
Christian Dorrer
M.-Pilar Marco

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2022.848501

4,673 views
1 citation

Case Report

Published on 19 Dec 2016

Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect

in Pharmacogenetics and Pharmacogenomics

Kuntheavy Ing Lorenzini
Youssef Daali
Pierre Fontana
Jules Desmeules
Caroline Samer

Frontiers in Pharmacology

doi 10.3389/fphar.2016.00494

8,803 views
58 citations

Original Research

Published on 04 May 2018

The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency

in Translational and Clinical Endocrinology

Jolanta Sawicka-Powierza
Jerzy Konstantynowicz
Ewa Jablonska
Beata Zelazowska-Rutkowska
Wojciech Jelski
Pawel Abramowicz
Caroline Sasinowski
Slawomir Chlabicz

Frontiers in Endocrinology

doi 10.3389/fendo.2018.00226

4,975 views
3 citations

Original Research

Published on 06 Apr 2020

A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort Study

in Pharmacogenetics and Pharmacogenomics

Angela Roco
Elena Nieto
Marcelo Suárez
Mario Rojo
Maria Paz Bertoglia
Gabriel Verón
Francisca Tamayo
Annabella Arredondo
Daniela Cruz
Jessica Muñoz

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00325

9,865 views
16 citations

Correction

Published on 31 Mar 2025

Corrigendum: A pharmacogenetically-guided acenocoumarol dosing algorithm for Chilean patients: a discovery cohort study

in Pharmacogenetics and Pharmacogenomics

Angela Roco
Elena Nieto
Marcelo Suárez
Mario Rojo
Maria Paz Bertoglia
Gabriel Verón
Francisca Tamayo
Annabella Arredondo
Daniela Cruz
Jessica Muñoz

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1588440

1,050 views
1 citation

Original Research

Published on 01 Aug 2025

Comparative clinical outcomes of acenocoumarol versus direct oral anticoagulants (DOACs) and warfarin in patients with atrial fibrillation: real-world-evidence (SIESTA-A study)

in Pharmacoepidemiology

Ma Carmen Montero-Balosa
Juan A. Limón-Mora
Ana Leal-Atienza
Beatriz García-Robredo
Pablo Sánchez-Villegas
Rebeca Isabel-Gómez
Ma José Aguado-Romeo
Luis Gabriel Luque Romero
Ma Teresa Molina-López

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1548298

2,704 views

Original Research

Published on 10 Dec 2021

Safety and Efficacy of Low Molecular Weight Heparin for Thromboprophylaxis in the Elderly: A Network Meta-Analysis of Randomized Clinical Trials

in Cardiovascular and Smooth Muscle Pharmacology

Hui-qin Yang
Man-cang Liu
Wen-jun Yin
Ling-yun Zhou
Xiao-cong Zuo

Frontiers in Pharmacology

doi 10.3389/fphar.2021.783104

8,916 views
5 citations

Articles

Development of a Fluorescent Microfluidic Device Based on Antibody Microarray Read-Out for Therapeutic Drug Monitoring of Acenocoumarol

Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect

The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency

A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort Study

Corrigendum: A pharmacogenetically-guided acenocoumarol dosing algorithm for Chilean patients: a discovery cohort study

Comparative clinical outcomes of acenocoumarol versus direct oral anticoagulants (DOACs) and warfarin in patients with atrial fibrillation: real-world-evidence (SIESTA-A study)

Safety and Efficacy of Low Molecular Weight Heparin for Thromboprophylaxis in the Elderly: A Network Meta-Analysis of Randomized Clinical Trials